On Jan. 6, 2025, the U.S. FDA issued draft guidance for developers of AI-enabled medical devices to bolster the safe, effective development and marketing of these tools throughout their product ...
The US Food and Drug Administration (FDA) recently issued its draft guidance, Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations ...
On January 7, 2025, FDA published a draft guidance titled “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations.” The draft guidance ...
Earlier this month, FDA released a new draft guidance document outlining recommendations for lifecycle management and marketing submissions of AI-enabled device software functions. The guidance ...
On January 6, 2024, FDA released draft guidance on Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations (the “draft guidance”). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results